Through qRT-PCR, we confirmed that AP001007.1, MIR155HG, and LBX2-AS1 are highly expressed, while LINC00515 and MAPT-AS1 are low expressed in gliomas compared to the control group (Figure 9A). Here, MAPT is linked to central nervous system cancer.